Endocrine effects of valproate in adolescent girls with epilepsy

Epilepsia

Volumn 48, Issue 3, 2007, Pages 470-477

  De Vries, Liat ^a   Karasik, Anna ^a   Landau, Zohar ^a   Phillip, Moshe ^a   Kiviti, Sara ^b,c   Goldberg Stern, Hadassa ^b,c  

^a National Center for Childhood Diabetes   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Epilepsy; Obesity; PCOS; Testosterone; Valproate

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID;

ACNE; ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY GROWTH; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENDOCRINE FUNCTION TEST; EPILEPSY; FEMALE; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; HIRSUTISM; HORMONAL REGULATION; HUMAN; HYPERANDROGENISM; LONG TERM CARE; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL IRREGULARITY; MONOTHERAPY; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT MONITORING; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; SAMPLE SIZE; SCHOOL CHILD; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE; TESTOSTERONE BLOOD LEVEL; THYROID HORMONE BLOOD LEVEL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTICONVULSANTS; BODY HEIGHT; BODY MASS INDEX; CHILD; COMORBIDITY; EPILEPSY; FEMALE; HUMANS; MENARCHE; OBESITY; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE; THYROTROPIN; THYROXINE; VALPROIC ACID;

EID: 33847618388     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00953.x     Document Type: Article

References (47)

1. Allard P, Delvin EE, Paradis G, Hanley JA, O'Loughlin J, Lavallee, Levy E, Lambert M. (2003) Distribution of fasting insulin, free fatty acids and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clinical Chemistry 49:644-649.
2. Bauer J, Jarre A, Klingmüller D, Elger CE. (2000) Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Research 41:163-167.
3. Berlit P, Krause KH, Heuch CC, Shellemberg B. (1982) Serum lipids and anticonvulsants. Acta Neurologica Scandinavica 66:328-334.
4. Bilo L, Meo R, Nappi C, Annunziato L, Striano S, Colao AM, Merola B, Buscaino GA. (1988) Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 29:612-619.
5. Bilo L, Meo R, Valentino R, Buscaino GA, Striano S, Nappi C. (1991) Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy. Fertility and Sterility 55:705-711.
6. Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. (2001) Characterization of reproductive endocrine disorders in women with epilepsy. Journal of Clinical Endocrinology and Metabolism 186:2950-2956.
7. Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399.
8. Cummings LN, Guidice L, Morrell MJ. (1995) Ovulatory function in epilepsy. Epilepsia 36:355-359.
9. Egger J, Brett EM. (1981) Effects of valproate in 100 children with special reference to weight. British Medical Journal 5:126-139.
10. El-Khayat HA, Abd El-Basset FZ, Tomoun HY, Tohamy SM, Zaky AA, Mohamed MS, Hakky SM, El Barbary NS, Nassef NM. (2004) Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. Epilepsia 45:1106-1115.
11. Ferriman D, Gallwey JD. (1961) Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 21:1440-1447.
12. Greulich WW, Pyle SI. (1959) Radiographic atlas of the skeletal development of the hand and wrist. 2nd ed. Stanford University Press, Stanford, CA.
13. Gungor N, Saad R, Janosky J, Arslanian S. (2004) Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. Journal of Pediatrics 144:47-55.
14. Guo CY, Ronen GM, Atkinson SA. (2001) Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 42:1141-1147.
15. Herzog AG. (1996) Temporolimbic epilepsy and polycystic ovary syndrome. Fertility and Sterility 65:210-211.
16. Herzog AG, Seibel MM, Schomer D, Vaitukaitis JL, Geshwind N. (1984) Temporal lobe epilepsy: an extrahypothalamic pathogenesis for polycystic ovary syndrome? Neurology 34:1389-1393.
17. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. (1986) Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Archives of Neurology 43:341-346.
18. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New England Journal of Medicine 329:1283-1288.
19. Isojärvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV. (1996) Obesity and endocrine disorders in women taking valproate for epilepsy. Annals of Neurology 39:579-584.
20. Jallon P, Picard F. (2001) Body weight gain and anticonvulsants: a comparative review. Drug Safety 24:969-978.
21. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM. (2000) CDC growth charts: United States advanced data from vital and health statistics. NCHS Advance Data Report No. 314, pp. 1-27. US Department of Health and Human Services, Hyattsville, MD.
22. Kurlemann G, Benner T, Brämswik HJ. (1997) Adult height and target height in 111 boys and 98 girls treated for epilepsy during childhood. Journal of Child Neurology 12:513-515.
23. Lissau I, Overpeck MD, Ruan WJ, Due P, Holstein BE, Hediger ML. (2004) Body mass index and overweight in adolescents in 13 European countries, Israel, and the United States. Archives of Pediatric and Adolescent Medicine 158:27-33.
24. Lohman TG. (1986) Applicability of body composition techniques and constants for children and youth. Exercise and Sport Sciences Review 14:325-357.
25. Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitener M, Bauer G. (2002) Polycystic ovaries, obesity and insulin resistance in women with epilepsy: a comparative study of carbamazepine and valproic acid in 105 women. Journal of Neurology 249:835-841.
26. Macardle BM, Mcgowan MEL, Greene SA, Miller CS. (1987) Anticonvulsant drugs, growth, and development. Archives of Diseases in Childhood 62:615-617.
27. Marshall WA, Tanner JM. (1969) Variations in the pattern of pubertal changes in girls. Archives of Diseases in Childhood 44:291-303.
28. Meo R, Bilo L, Nappi C, Tommaselli AP, Valentino R, Nocerino C, Striano S, Buscaino GA. (1993) Derangement of the hypothalamic GnRH pulse generator in women with epilepsy. Seizure 2:241-252.
29. Mikkonen K, Knip M, Pakarinen AJ, Lanning P, Isojärvi IT, Vainionpää LK. (2005) Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation. Epilepsia 46:1114-1120.
30. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A. (2004) Measurements of free testosterone in normal women and women with androgen deficiency: comparison of methods. Journal of Clinical Endocrinology and Metabolism 89:525-533.
31. Murialdo G, Galimberti CA, Magri F, Sampaolo P, Copello F, Gianelli MV, Gazzerro E, Rollero A, Degatone C, Manni R, Ferrari E, Polleri A, Tertara A. (1997) Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. Journal of Endocrinological Investigation 20:519-526.
32. Murialdo G, Galimberti CA, Gianelli MV, Rollero A, Polleri A, Copello F, Magri F, Ferrari E, Sampaolo P, Manni R, Tertara A. (1998) Effects of valproate, phenobarbital and carbamazepine on sex steroid setup in women with epilepsy. Clinical Neuropharmacology 21:52-58.
33. Nappi C, Meo R, Di Carlo C, Estraneo A, Bilo L. (1994) Reduced fertility and neuroendocrine dysfunction in women with epilepsy. Gynecologic Endocrinology 8:133-145.
34. Nelson-DeGrave VL, Wickenheisser JK, Cockrell JE, Wood JR, Legro RS, Strauss JF 3rd, McAllister JM. (2004) Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology 145:799-808.
35. Pecoraro P, Guida B, Caroli M, Falconi C, Principato S, Pietrobelli A. (2003) Body mass index and skinfold thickness versus bioimpedance analysis: fat mass prediction in children. Acta Diabetologica 40:S278-S281.
36. Rättyä J, Vainionpää LK, Mikkonen K, Knip M, Lanning P, Isojärvi JIT. (1999) The effects of valproate, carbamazepine and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics 103:588-593.
37. Rättyä J, Pakarinen AJ, Knip M, Repo-Outakoski M, Myllylä VV, Isojärvi IT. (2001) Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 57:440-444.
38. Reddy MN. (1985) Effects of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol and apolipoproteins A and B in children with epilepsy. Proceedings of the Society for Experimental Biology and Medicine 180:359-363.
39. Rosner B, Prineas R, Loggie J, Daniels SR. (1998) Percentiles for body mass index in US children 5 to 17 years of age. Journal of Pediatrics 132:211-222.
40. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81:19-25.
41. Schmidt D. (1984) Adverse effects of valproate. Epilepsia 25(suppl 1):S44-S49.
42. Snyder P, Badura LL. (1998) A potential mechanism of slowed puberty maturation after chronic administration of sodium valproic acid. Neurology 50:922-925.
43. Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie M. (2001) Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 42:1002-1006.
44. Tauboøll E, Gregraszczuk EL, Kolodziej A, Kajta M, Ropstad E. (2003) Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia 44:1014-1021.
45. Vainionpää LK, Rättyä J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, Tekay A, Myllylä VV, Isojärvi JIT. (1999) Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology 45:444-450.
46. Vainionpää LK, Mikkonen K, Rättyä J, Knip M, Pakarinen AJ, Myllylä VV, Isojärvi JIT. (2004) Thyroid functions in girls with epilepsy with carbamazepine, oxcarbazepine or valproate monotherapy and after withdrawal of medication. Epilepsia 45:197-203.
47. Verrotti A, Basciani F, Morresi S, Morgese G, Chiarelli F. (2001) Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatric Neurology 25:43-46.